| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | 8.277 | 31.120 | 43.552 | 44.860 |
| Total Income - EUR | - | - | - | - | - | - | 8.277 | 31.120 | 43.552 | 44.860 |
| Total Expenses - EUR | - | - | - | - | - | - | 884 | 2.501 | 2.422 | 11.370 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | 7.393 | 28.619 | 41.130 | 33.490 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | 7.150 | 27.768 | 35.812 | 33.108 |
| Employees | - | - | - | - | - | - | 0 | 0 | 1 | 1 |
Check the financial reports for the company - Exclusive Pharma S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | 926 | 592 | 1.029 | 1.361 |
| Current Assets | - | - | - | - | - | - | 9.567 | 27.695 | 51.257 | 82.267 |
| Inventories | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | - | - | 0 | 16.646 | 4.706 | 3.509 |
| Cash | - | - | - | - | - | - | 9.567 | 11.049 | 46.552 | 78.758 |
| Shareholders Funds | - | - | - | - | - | - | 7.191 | 27.817 | 49.760 | 82.591 |
| Social Capital | - | - | - | - | - | - | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | - | 3.303 | 469 | 2.526 | 1.037 |
| Income in Advance | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4791 - 4791" | |||||||||
| CAEN Financial Year |
4791
|
|||||||||
Comments - Exclusive Pharma S.r.l.